Primary record
5-({3-[5-(trifluoromethyl)-1H-1,3-benzodiazol-2-yl]-5-oxatricyclo[4.4.0.0(2),?]deca-1(10),6,8-trien-9-yl}oxy)-3,4-dihydro-1H-1,8-naphthyridin-2-one
- 库存
- 1,937 克
- 纯度
- 98.2 %
- CAS
- 1446090-77-2
化合物标识与属性
- CAS
- 1446090-77-2
- PubChem CID
- 71622942
- SMILES
- C1CC(=O)NC2=NC=CC(=C21)OC3=CC4=C(C=C3)OC5C4C5C6=NC7=C(N6)C=C(C=C7)C(F)(F)F
- Canonical SMILES
- O=C1CCc2c(Oc3ccc4c(c3)C3C(O4)C3c3nc4ccc(C(F)(F)F)cc4[nH]3)ccnc2N1
名称与同义词
- Beigene-283
- Lifirafenib (BGB-283)
- BGB-283
- BGB283
- CHEMBL3901590
- SCHEMBL15085317
- NGFFVZQXSRKHBM-UHFFFAOYSA-N
- BDBM210038
- BCP09509
- CCG-269525
- SB19739
- DB-185128
- US9273046, 2.2
- 1446090-77-2
- 1446090-79-4
- 5-((1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one
- BGB-283;BGB 2833; Beigene-283; Beigene283; Beigene 283; Lifirafenib
- 5-({3-[5-(trifluoromethyl)-1H-1,3-benzodiazol-2-yl]-5-oxatricyclo[4.4.0.0(2),?]deca-1(10),6,8-trien-9-yl}oxy)-3,4-dihydro-1H-1,8-naphthyridin-2-one
- 5-({3-[5-(trifluoromethyl)-1H-1,3-benzodiazol-2-yl]-5-oxatricyclo[4.4.0.0(2),?]deca-1(6),7,9-trien-9-yl}oxy)-3,4-dihydro-1H-1,8-naphthyridin-2-one
- 5-[[(1S,1aR,6bS)-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzo